Tunisia has observed a 9% (29.0%) increase in the pregnant women living with hiv antiretroviral therapy coverage for pmtct, which now stands at 40%.
Pregnant women living with HIV antiretroviral therapy coverage for PMTCT in Tunisia
No matching regions
Source:
Data availability:
Regions:
215
Date range: 2000 to 2022
Points:
13,760
Measure:
%
Similar regions to Tunisia
PMTCT antiretroviral therapy coverage
More indicators for Tunisia
Male unintentional poisoning
0.9
0.0
(2019)
Female wasting in children
2.1%
+0.3%
(2018)
Female prevalence of HIV
0.1%
0%
(2022)
Out-of-pocket expenditure PPP per capita
intl dollar265
+intl dollar15
(2021)
Birth registration
99.9%
+0.9%
(2018)
Contraceptive modern method prevalence
44.3%
-6.6%
(2018)
Tunisia PMTCT antiretroviral therapy coverage between 2000 and 2022
| Period | PMTCT antiretroviral therapy coverage | Change |
|---|---|---|
| 2022 | 40% | +9% |
| 2021 | 31% | +3% |
| 2020 | 28% | +10% |
| 2019 | 18% | +6% |
| 2018 | 12% | +1% |
| 2017 | 11% | -1% |
| 2016 | 12% | -5% |
| 2015 | 17% | -9% |
| 2014 | 26% | +14% |
| 2013 | 12% | +3% |
| 2012 | 9% | -1% |
| 2011 | 10% | +1% |
| 2010 | 9% | +6% |
| 2009 | 3% | 0% |
| 2008 | 3% | +1% |
| 2007 | 2% | +2% |
| 2006 | 0% | 0% |
| 2005 | 0% | -3% |
| 2004 | 3% | -3% |
| 2003 | 6% | +2% |
| 2002 | 4% | +4% |
| 2001 | 0% | 0% |
| 2000 | 0% |